FR2488509A1 - Nouvelles compositions pharmaceutiques contenant de l'almitrine - Google Patents

Nouvelles compositions pharmaceutiques contenant de l'almitrine Download PDF

Info

Publication number
FR2488509A1
FR2488509A1 FR8018074A FR8018074A FR2488509A1 FR 2488509 A1 FR2488509 A1 FR 2488509A1 FR 8018074 A FR8018074 A FR 8018074A FR 8018074 A FR8018074 A FR 8018074A FR 2488509 A1 FR2488509 A1 FR 2488509A1
Authority
FR
France
Prior art keywords
almitrine
doses
ventilation
blood
respiratory
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR8018074A
Other languages
English (en)
French (fr)
Other versions
FR2488509B1 (enExample
Inventor
Etienne Labeyrie
Jean-Pierre Poirier
Francoise Arnaud
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Science Union et Cie
Original Assignee
Science Union et Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Science Union et Cie filed Critical Science Union et Cie
Priority to FR8018074A priority Critical patent/FR2488509A1/fr
Priority to IT49104/81A priority patent/IT1171461B/it
Priority to LU83556A priority patent/LU83556A1/fr
Priority to GR65808A priority patent/GR75328B/el
Priority to NZ198062A priority patent/NZ198062A/xx
Priority to ZA815664A priority patent/ZA815664B/xx
Priority to CA000383989A priority patent/CA1181694A/fr
Priority to US06/294,014 priority patent/US4364946A/en
Priority to AU74277/81A priority patent/AU550741B2/en
Priority to DE19813132654 priority patent/DE3132654A1/de
Priority to CH5348/81A priority patent/CH650152A5/fr
Priority to BE0/205710A priority patent/BE890011A/fr
Priority to IE1891/81A priority patent/IE52095B1/en
Priority to GB8125188A priority patent/GB2082064B/en
Publication of FR2488509A1 publication Critical patent/FR2488509A1/fr
Application granted granted Critical
Publication of FR2488509B1 publication Critical patent/FR2488509B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR8018074A 1980-08-18 1980-08-18 Nouvelles compositions pharmaceutiques contenant de l'almitrine Granted FR2488509A1 (fr)

Priority Applications (14)

Application Number Priority Date Filing Date Title
FR8018074A FR2488509A1 (fr) 1980-08-18 1980-08-18 Nouvelles compositions pharmaceutiques contenant de l'almitrine
IT49104/81A IT1171461B (it) 1980-08-18 1981-08-13 Composizione a base di almitrina e suo impiego in terapia
LU83556A LU83556A1 (fr) 1980-08-18 1981-08-14 Nouvelles compositions pharmaceutiques contenant de l'almitrine
NZ198062A NZ198062A (en) 1980-08-18 1981-08-17 Oral pharmaceutical dosage form containing almitrine
ZA815664A ZA815664B (en) 1980-08-18 1981-08-17 Treating insufficiencies in hematosis with almitrine
CA000383989A CA1181694A (fr) 1980-08-18 1981-08-17 Compositions pharmaceutiques contenant de l'almitrine
GR65808A GR75328B (enExample) 1980-08-18 1981-08-17
AU74277/81A AU550741B2 (en) 1980-08-18 1981-08-18 Oral composition for treatment of hematosis containing almitrin
DE19813132654 DE3132654A1 (de) 1980-08-18 1981-08-18 Arzneimittel zur behandlung von blutsauerstoffversorgungsstoerungen
CH5348/81A CH650152A5 (fr) 1980-08-18 1981-08-18 Composition pharmaceutique contenant de l'almitrine.
BE0/205710A BE890011A (fr) 1980-08-18 1981-08-18 Nouvelles compositions pharmaceutiques contenant de l'almitrine
IE1891/81A IE52095B1 (en) 1980-08-18 1981-08-18 Pharmaceutical preparations for treating insufficiencies in haematosis
US06/294,014 US4364946A (en) 1980-08-18 1981-08-18 Method of treating insufficiencies in hematosis with almitrine
GB8125188A GB2082064B (en) 1980-08-18 1981-08-18 Pharmaceutical preparations containing almitrine for treating insufficiencies in haematosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8018074A FR2488509A1 (fr) 1980-08-18 1980-08-18 Nouvelles compositions pharmaceutiques contenant de l'almitrine

Publications (2)

Publication Number Publication Date
FR2488509A1 true FR2488509A1 (fr) 1982-02-19
FR2488509B1 FR2488509B1 (enExample) 1984-11-23

Family

ID=9245242

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8018074A Granted FR2488509A1 (fr) 1980-08-18 1980-08-18 Nouvelles compositions pharmaceutiques contenant de l'almitrine

Country Status (14)

Country Link
US (1) US4364946A (enExample)
AU (1) AU550741B2 (enExample)
BE (1) BE890011A (enExample)
CA (1) CA1181694A (enExample)
CH (1) CH650152A5 (enExample)
DE (1) DE3132654A1 (enExample)
FR (1) FR2488509A1 (enExample)
GB (1) GB2082064B (enExample)
GR (1) GR75328B (enExample)
IE (1) IE52095B1 (enExample)
IT (1) IT1171461B (enExample)
LU (1) LU83556A1 (enExample)
NZ (1) NZ198062A (enExample)
ZA (1) ZA815664B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2660558B1 (fr) * 1990-04-05 1994-09-09 Adir Utilisation de l'almitrine pour l'obtention de medicaments destines au traitement du paludisme.
US8453522B2 (en) * 2009-07-31 2013-06-04 Mts Systems Corporation Wind turbine drive train test assembly
CA3087881A1 (en) 2017-01-17 2018-07-26 Michael David FORREST Therapeutic inhibitors of the reverse mode of atp synthase
US12337000B2 (en) * 2017-07-13 2025-06-24 Michael David FORREST Therapeutic modulators of the reverse mode of ATP synthase

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2019646A1 (enExample) * 1968-10-02 1970-07-03 Science Union & Cie

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2019646A1 (enExample) * 1968-10-02 1970-07-03 Science Union & Cie

Also Published As

Publication number Publication date
FR2488509B1 (enExample) 1984-11-23
IT8149104A1 (it) 1983-02-13
IT1171461B (it) 1987-06-10
GR75328B (enExample) 1984-07-13
BE890011A (fr) 1982-02-18
NZ198062A (en) 1983-12-16
CA1181694A (fr) 1985-01-29
IE52095B1 (en) 1987-06-10
IT8149104A0 (it) 1981-08-13
CH650152A5 (fr) 1985-07-15
GB2082064A (en) 1982-03-03
DE3132654A1 (de) 1982-06-24
US4364946A (en) 1982-12-21
AU7427781A (en) 1982-02-25
AU550741B2 (en) 1986-04-10
IE811891L (en) 1982-02-18
GB2082064B (en) 1985-06-26
ZA815664B (en) 1982-08-25
LU83556A1 (fr) 1982-04-14

Similar Documents

Publication Publication Date Title
Meldrum et al. Physiology of status epilepticus in primates
Guth et al. Elimination of exercise-induced regional myocardial dysfunction by a bradycardiac agent in dogs with chronic coronary stenosis.
EP0440704B1 (en) Compositions for treating tobacco withdrawel symptoms
Ebert et al. Circulatory responses to laryngoscopy: the comparative effects of placebo, fentanyl and esmolol
MXPA01007350A (es) Derivados anticonvulsivos utiles en el tratamiento de cefalea acuminada.
US20140271890A1 (en) Controlled-release pharmaceutical composition
US5466700A (en) Anesthetic use of N-phenyl-N-(4-piperidinyl)amides
FR2488509A1 (fr) Nouvelles compositions pharmaceutiques contenant de l'almitrine
BG65637B1 (bg) Използване на мелатонин във форма с контролирано освождаване за лечение на резистентност към антихипертензивни препарати и подобни състояния
Lehtonen et al. Doxazosin effects on insulin and glucose in hypertensive patients
Navelet et al. Nocturnal sleep organization in infants “at risk” for sudden infant death syndrome
FR2634379A1 (fr) Utilisation en therapeutique des benzo(g)quinoleines pour le traitement de la dependance a la nicotine
McCulloch et al. Large lung volumes delay the onset of the physiological breaking point during simulated diving
Windle et al. Influence of carbon dioxide and anoxemia upon respiration in the chick at hatching
JPH01186883A (ja) 抗アテローム性動脈硬化症剤としてのｄｌ‐５‐〔（２ベンジル‐３，４‐ジヒドロ‐２Ｈ‐ベンゾピラン‐６‐イル）メチル〕チアゾリジン‐２，４‐ジオン
Hutchins et al. Effect of isoproterenol on the blood vessels of the spontaneously hypertensive rat
US20200085849A1 (en) Methods and compositions for improving sleep
Gaba et al. Comparison of pulmonary and systemic effects of adenosine triphosphate in chronic obstructive pulmonary disease--ATP: a pulmonary controlled vasoregulator?
Parratt The haemodynamic effects of prolonged oral administration of oxyfedrine, a partial agonist at β‐adrenoceptors: comparison with propranolol
Flenley et al. Cardiovascular effects of oxygen therapy for pulmonary arterial hypertension
Rosenzweig et al. Neurobiology and physiology of sleep and breathing
Svedmyr et al. Effects of sotalol and propranolol administered orally in man
CA2362336C (en) Anticonvulsant derivatives useful in treating essential tremor
Glick et al. Titration of oral nicotine intake with smoking behaviour in monkeys
US20030181459A1 (en) Use of a vitamin combination for the treatment of primary headaches

Legal Events

Date Code Title Description
ST Notification of lapse